Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
EyePoint Inc (EyePoint), formerly EyePoint Pharmaceuticals Inc, is a specialty biopharmaceutical company focused on developing and commercializing innovative ophthalmic products. The company offers therapeutics for serious retinal diseases using sustained-release drug delivery technologies. Its pipeline products include EYP-1901 which targets wet age-related macular degeneration (Wet AMD), non-proliferative diabetic retinopathy (NPDR) and diabetic macularedema (DME); EYP-2301 for serious retinal diseases. The company collaborates with partners to expand the applicability of its technologies across various therapeutic areas. EyePoint is headquartered in Watertown, Massachusetts, the US.
Headquarters
United States of America
Address
Suite C-400, 480 Pleasant Street, Watertown, Massachusetts, 02472
Website
www.eyepoint.bio
Telephone
1 617 9265000
No of Employees
214
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
EYPT (NASD)
Revenue (2025)
$31.4M
Market Cap*
$1.2B
* As of and is in US$
EyePoint Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| EYP-1901: |
| Wet Age-Related Macular Degeneration |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | EyePoint Inc | Outlook Therapeutics Inc | Hyperion DeFi Inc | Radius Health Inc |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | Watertown | Iselin | New York City | Boston |
| State/Province | Massachusetts | New Jersey | New York | Massachusetts |
| No. of Employees | 214 | 17 | 13 | 293 |
| Entity Type | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Goran Ando, MD | Chairman | Executive Board | 2018 | 76 |
| Nancy Lurker | Vice Chairman | Executive Board | 2023 | 67 |
| Jay S. Duker, M.D | Chief Executive Officer; President; Director | Executive Board | 2023 | 66 |
| George O. Elston | Executive Vice President; Chief Financial Officer | Senior Management | 2019 | 59 |
| Ron Honig | Secretary; Chief Legal Officer | Senior Management | 2018 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer